Log in to save to my catalogue

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their associat...

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their associat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5068194

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

About this item

Full title

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

Publisher

England: John Wiley & Sons, Inc

Journal title

The journal of pathology. Clinical research, 2016-10, Vol.2 (4), p.234-246

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Dysfunctional telomeres and DNA damage repair (DDR) play important roles in cancer progression. Studies have reported correlations between these factors and tumour aggressiveness and clinical outcome in breast cancer. We studied the characteristics of telomeres and expression of ERCC1, a protein involved in a number of DNA repair pathways and in te...

Alternative Titles

Full title

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5068194

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5068194

Other Identifiers

ISSN

2056-4538

E-ISSN

2056-4538

DOI

10.1002/cjp2.52

How to access this item